DERM Journey Medical CorpcompanySEC Filings & Insider Trading Activity 2026
Latest Journey Medical Corp (DERM) SEC EDGAR filings in 2026 — including the most recent 10-K annual report filed on March 26, 2026, a 10-Q quarterly report filed on November 12, 2025, an 8-K current report filed on April 21, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for Journey Medical Corp (DERM) (SEC CIK 1867066), with AI-powered section-by-section summaries updated daily.
Latest 2026 SEC Filing Dates
Latest 2026 SEC Filings — 10-K, 10-Q, 8-K & Form 4
Frequently Asked Questions
What are the latest DERM SEC filings in 2026?
Journey Medical Corp (DERM) has filed a 10-K annual report on March 26, 2026, a 10-Q quarterly report on November 12, 2025, an 8-K current report on April 21, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.
When did DERM file its most recent 10-K annual report?
Journey Medical Corp (DERM) filed its most recent 10-K annual report on March 26, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.
How do I view DERM 10-Q quarterly reports?
Journey Medical Corp (DERM)'s most recent 10-Q quarterly report was filed on November 12, 2025. SignalX displays every DERM 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.
What 8-K current reports has DERM filed recently?
Journey Medical Corp (DERM)'s most recent 8-K was filed on April 21, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.
Where can I find DERM insider trading activity (Form 4)?
SignalX aggregates every DERM Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.
How often does DERM file with the SEC?
Journey Medical Corp (DERM) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new DERM filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs — such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for Journey Medical Corp (DERM).
What is DERM's SEC CIK number?
Journey Medical Corp (DERM)'s SEC CIK (Central Index Key) number is 1867066. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1867066 to look up all DERM filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Where can I find DERM return on equity (ROE) and financial data?
SignalX extracts XBRL financial data from Journey Medical Corp (DERM) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.
Stay on top of Journey Medical Corp SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 20+ filings.